Entity: U.S. federal health reform law (2010)

U.S. federal health reform law (2010)

1 Facts

2 Related Topics

A 2010 U.S. federal health reform law directed the Food and Drug Administration (FDA) to establish an approval pathway for biosimilar drugs.

January 01, 2010 high legal

Legislative origin of the U.S. biosimilars pathway.

Health Economy